The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Hyaluronan molecular weight: Effects on dissolution time of dissolving microneedles in the skin and on immunogenicity of antigen
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Further, our MNs had 673.06 ± 5.34 µg of MNC per array which is considered a high drug loading value compared to other previously reported MNs for antibiotic delivery [43].”
From Formulation and Characterization of PLGA Minocycline Microneedles for Enhanced Skin Deposition and Antibacterial Activity in Acne Treatment (2025) · cites this paper as [43]
In the citing paper
“MNs fabricated from other polymers such as hyaluronic acid might require much longer time to dissolve [43].”
From Formulation and Characterization of PLGA Minocycline Microneedles for Enhanced Skin Deposition and Antibacterial Activity in Acne Treatment (2025) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oligosaccharides of Hyaluronan Activate Dendritic Cells via Toll-like Receptor 4
Termeer, C., Benedix, F., Sleeman, J., Fieber, C., Voith, U., Ahrens, T., Miyake, K., Freudenberg, M., Galanos, C., & Simon, J. C. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20001858 · Cited by 1,378
Hyaluronan as an Immune Regulator in Human Diseases
Jiang, D., Liang, J., & Noble, P. W. (2011) · Physiological Reviews · doi:10.1152/physrev.00052.2009 · Cited by 1,060
Hyaluronan digestion controls DC migration from the skin
Muto, J., Morioka, Y., Yamasaki, K., Kim, M., Garcia, A., Carlin, A. F., Varki, A., & Gallo, R. L. (2014) · Journal of Clinical Investigation · doi:10.1172/jci67947 · Cited by 84
Research works printed but not linked: 49
- Hirobe, 2015, Clinical study and stability assessment of a novel transcutaneous influenza vaccination using a dissolving microneedle patch, Biomaterials, 57, 50, 10.1016/j.biomaterials.2015.04.007 · DOI · Paper page
- Arya, 2017, Tolerability, usability and acceptability of dissolving microneedle patch administration in human subjects, Biomaterials, 128, 1, 10.1016/j.biomaterials.2017.02.040 · DOI · Paper page
- Leone, 2017, Dissolving microneedle patches for dermal vaccination, Pharm. Res., 34, 2223, 10.1007/s11095-017-2223-2 · DOI
- van der Maaden, 2012, Microneedle technologies for (trans)dermal drug and vaccine delivery, J. Control. Release, 161, 645, 10.1016/j.jconrel.2012.01.042 · DOI · Paper page
- Larraneta, 2016, Microneedle arrays as transdermal and intradermal drug delivery systems: materials science, manufacture and commercial development, Mat. Sci. Eng. R., 104, 1, 10.1016/j.mser.2016.03.001 · DOI · Paper page
- Larraneta, 2016, Microneedles: a new frontier in nanomedicine delivery, Pharm. Res., 33, 1055, 10.1007/s11095-016-1885-5 · DOI · Paper page
- Tuan-Mahmood, 2013, Microneedles for intradermal and transdermal drug delivery, Eur. J. Pharm. Sci., 50, 623, 10.1016/j.ejps.2013.05.005 · DOI · Paper page
- van der Maaden, 2015, Microneedle-based drug and vaccine delivery via nanoporous microneedle arrays, Drug Deliv. Transl. Re, 5, 397, 10.1007/s13346-015-0238-y · DOI
- Hirobe, 2013, Development and clinical study of a self-dissolving microneedle patch for transcutaneous immunization device, Pharm. Res-Dordr., 30, 2664, 10.1007/s11095-013-1092-6 · DOI
- Leone, 2019, Hyaluronan-based dissolving microneedles with high antigen content for intradermal vaccination: formulation, physicochemical characterization and immunogenicity assessment, Eur. J. Pharm. Biopharm., 134, 49, 10.1016/j.ejpb.2018.11.013 · DOI
- Matsuo, 2014, Transcutaneous immunization using a dissolving microneedle array protects against tetanus, diphtheria, malaria, and influenza (vol 160, pg 495, 2012), J. Control. Release, 184, 18, 10.1016/j.jconrel.2014.04.001 · doi:10.1016/j.jconrel.2014.04.001
- Matsuo, 2014, A low-invasive and effective transcutaneous immunization system using a novel dissolving microneedle array for soluble and particulate antigens (vol 161, pg 10, 2012), J. Control. Release, 184, 10.1016/j.jconrel.2014.04.002 · doi:10.1016/j.jconrel.2014.04.002
- Zhu, 2016, Transcutaneous immunization via rapidly dissolvable microneedles protects against hand-foot-and-mouth disease caused by enterovirus 71, J. Control. Release, 243, 291, 10.1016/j.jconrel.2016.10.019 · DOI
- Oh, 2010, Target specific and long-acting delivery of protein, peptide, and nucleotide therapeutics using hyaluronic acid derivatives, J. Control. Release, 141, 2, 10.1016/j.jconrel.2009.09.010 · DOI · Paper page
- Ito, 2011, Two-layered dissolving microneedles for percutaneous delivery of sumatriptan in rats, Drug Dev. Ind. Pharm., 37, 1387, 10.3109/03639045.2011.576426 · DOI
- Liu, 2012, The development and characteristics of novel microneedle arrays fabricated from hyaluronic acid, and their application in the transdermal delivery of insulin, J. Control. Release, 161, 933, 10.1016/j.jconrel.2012.05.030 · DOI · Paper page
- Liu, 2016, Improvement of transdermal delivery of exendin-4 using novel tip-loaded microneedle arrays fabricated from hyaluronic acid, Mol. Pharm., 13, 272, 10.1021/acs.molpharmaceut.5b00765 · DOI
- Noble, 2002, Hyaluronan and its catabolic products in tissue injury and repair, Matrix Biol., 21, 25, 10.1016/S0945-053X(01)00184-6 · DOI · Paper page
- Termeer, 2000, Oligosaccharides of hyaluronan are potent activators of dendritic cells, J. Immunol., 165, 1863, 10.4049/jimmunol.165.4.1863 · DOI · Paper page
- Agren, 1997, Reactive oxygen species contribute to epidermal hyaluronan catabolism in human skin organ culture, Free Radic. Biol. Med., 23, 996, 10.1016/S0891-5849(97)00098-1 · DOI
- Noble, 1996, Hyaluronan fragments activate an NF-kappa B/I-kappa B alpha autoregulatory loop in murine macrophages, J. Exp. Med., 183, 2373, 10.1084/jem.183.5.2373 · DOI · Paper page
- Hart, 1997, Dendritic cells: unique leukocyte populations which control the primary immune response, Blood, 90, 3245, 10.1182/blood.V90.9.3245 · DOI · Paper page
- Lesley, 1994, Hyaluronan-Binding function of Cd44 is transiently activated on T-Cells during an in-Vivo immune-response, J. Exp. Med., 180, 383, 10.1084/jem.180.1.383 · DOI
- Mizrahy, 2011, Hyaluronan-coated nanoparticles: the influence of the molecular weight on CD44-hyaluronan interactions and on the immune response, J. Control. Release, 156, 231, 10.1016/j.jconrel.2011.06.031 · DOI · Paper page
- Termeer, 2003, Hyaluronan – magic glue for the regulation of the immune response?, Trends Immunol., 24, 112, 10.1016/S1471-4906(03)00029-2 · DOI
- Kono, 2008, How dying cells alert the immune system to danger, Nature Rev. Immunol., 8, 279, 10.1038/nri2215 · DOI · Paper page
- Leone M., M.I. Priester, S. Romeijn, M.R. Nejadnik, J. Monkare, C. O'Mahony, W. Jiskoot, G. Kersten, J. Bouwstra. Hyaluronan-based dissolving microneedles with high antigen content for intradermal vaccination: formulation, physicochemical characterization and immunogenicity assessment. In.(Manuscript submitted for pubblication); 2018. · DOI
- Wilke, 2006, The evolution from convex corner undercut towards microneedle formation: theory and experimental verification, J. Micromech. Microeng., 16, 808, 10.1088/0960-1317/16/4/018 · DOI
- Schipper, 2016, Determination of depth-dependent intradermal immunogenicity of adjuvanted inactivated polio vaccine delivered by microinjections via hollow microneedles, Pharm. Res., 33, 2269, 10.1007/s11095-016-1965-6 · DOI
- van der Maaden, 2014, Novel hollow microneedle technology for depth-controlled microinjection-mediated dermal vaccination: a study with polio vaccine in rats, Pharm. Res., 31, 1846
- Leone, 2018, Universal applicator for digitally-controlled pressing force and impact velocity insertion of microneedles into skin, Pharmaceutics, 10, 10.3390/pharmaceutics10040211 · doi:10.3390/pharmaceutics10040211
- van der Maaden, 2014, Impact-insertion applicator improves reliability of skin penetration by solid microneedle arrays, AAPS J., 16, 681, 10.1208/s12248-014-9606-7 · doi:10.1208/s12248-014-9606-7
- D'Agostino, 2017, Is molecular size a discriminating factor in hyaluronan interaction with human cells?, Carbohyd. Polym., 157, 21, 10.1016/j.carbpol.2016.07.125 · DOI
- Rayahin, 2015, High and low molecular weight hyaluronic acid differentially influence macrophage activation, Acs. Biomater. Sci. Eng., 1, 481, 10.1021/acsbiomaterials.5b00181 · DOI · Paper page
- Topazio, 2014, Could hyaluronic acid (HA) reduce Bacillus Calmette–Guerin (BCG) local side effects? results of a pilot study, BMC Urol., 14, 10.1186/1471-2490-14-64 · doi:10.1186/1471-2490-14-64
- Zamboni, 2018, The potential of hyaluronic acid in immunoprotection and immunomodulation: chemistry, processing and function, Prog. Mater Sci., 97, 97, 10.1016/j.pmatsci.2018.04.003 · DOI · Paper page
- Litwiniuk, 2016, Hyaluronic acid in inflammation and tissue regeneration, Wounds, 28, 78
- Chanmee, 2016, Hyaluronan: a modulator of the tumor microenvironment, Cancer Lett., 375, 20, 10.1016/j.canlet.2016.02.031 · DOI · Paper page
- Bollyky, 2007, Cutting edge: high molecular weight hyaluronan promotes the suppressive effects of CD4+CD25+ regulatory T cells, J. Immunol., 179, 744, 10.4049/jimmunol.179.2.744 · DOI · Paper page
- Hsu, 2006, The role of CD4(+)CD25(+) T cells in autoantibody production in murine lupus, Clin. Exp. Immunol., 145, 513, 10.1111/j.1365-2249.2006.03173.x · DOI
- Hodge-Dufour, 1997, Induction of IL-12 and chemokines by hyaluronan requires adhesion-dependent priming of resident but not elicited macrophages, J. Immunol., 159, 2492, 10.4049/jimmunol.159.5.2492 · DOI · Paper page
- Horton, 1998, Regulation of hyaluronan-induced chemokine gene expression by IL-10 and IFN-gamma in mouse macrophages, J. Immunol., 160, 3023, 10.4049/jimmunol.160.6.3023 · DOI
- McKee, 1996, Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44, J. Clin. Invest., 98, 2403, 10.1172/JCI119054 · DOI · Paper page
- Noble, 1993, Hyaluronate activation of CD44 induces insulin-like growth factor-1 expression by a tumor necrosis factor-alpha-dependent mechanism in murine macrophages, J. Clin. Invest., 91, 2368, 10.1172/JCI116469 · DOI · Paper page
- Stern, 2006, Hyaluronan fragments: an information-rich system, Eur. J. Cell Biol., 85, 699, 10.1016/j.ejcb.2006.05.009 · DOI · Paper page
- Keijzer, 2011, PLGA, PLGA-TMC and TMC-TPP nanoparticles differentially modulate the outcome of nasal vaccination by inducing tolerance or enhancing humoral immunity, PLoS ONE, 6, e26684, 10.1371/journal.pone.0026684 · DOI
- Benne, 2018, Anionic 1,2-distearoyl-sn-glycero-3-phosphoglycerol (DSPG) liposomes induce antigen-specific regulatory T cells and prevent atherosclerosis in mice, J. Control. Release, 291, 135, 10.1016/j.jconrel.2018.10.028 · DOI
- Monkare, 2015, IgG-loaded hyaluronan-based dissolving microneedles for intradermal protein delivery, J. Control. Release, 218, 53, 10.1016/j.jconrel.2015.10.002 · doi:10.1016/j.jconrel.2015.10.002
- Passi, 2019, Hyaluronan as tunable drug delivery system, Adv. Drug Deliver Rev., 146, 83, 10.1016/j.addr.2019.08.006 · DOI
Cited by
Rational Design of Immunomodulatory Hydrogels for Chronic Wound Healing
Kharaziha, M., Baidya, A., & Annabi, N. (2021) · Advanced Materials · doi:10.1002/adma.202100176 · Cited by 721
Abu Ershaid, J. M., Abudoleh, S. M., Lafi, D. N., & Dahshan, N. A. (2025) · Polymers · doi:10.3390/polym17212912 · Cited by 5
Metadata
- Authors
- Leone, M., Romeijn, S., Slütter, B., O’Mahony, C., Kersten, G., & Bouwstra, J. A.
- ORCID
- O’Mahony, Conor
- Venue
- European Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2020-04
- Volume
- 146
- Pages
- 105269
- ISSN
- 0928-0987
- Cited by
- 47
- References
- 3
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hyaluronan molecular weight: Effects on dissolution time of dissolving microneedles in the skin and on immunogenicity of antigen. https://app.cochat.ai/papers/10.1016/j.ejps.2020.105269
- The paper
- Leone, M., Romeijn, S., Slütter, B., O’Mahony, C., Kersten, G., & Bouwstra, J. A. (2020). Hyaluronan molecular weight: Effects on dissolution time of dissolving microneedles in the skin and on immunogenicity of antigen. European Journal of Pharmaceutical Sciences. https://doi.org/10.1016/j.ejps.2020.105269
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.